Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Stoke Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of STOK: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1982197+1
Shares71.1M1.61M76.2M+6.74M (+9.7%)
Value$2.31B$52.5M$2.49B+$232.2M (+10.3%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to STOK in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC1,814,408$59.4M0.02%
Norges Bank163,200$5.34M0.00%
ExodusPoint Capital Management, LP129,660$4.24M0.04%
Jump Financial, LLC104,350$3.41M0.03%
Trexquant Investment LP73,475$2.40M0.01%
Two Sigma Investments, LP62,371$2.04M0.00%
Panagora Asset Management Inc58,843$1.93M0.01%
CI Private Wealth, LLC30,823$1.01M0.00%
Squarepoint Ops LLC29,310$959.0K0.00%
Aquatic Capital Management LLC15,471$506.2K0.02%
Jain Global LLC10,883$356.1K0.00%
Yorktown Management & Research Co Inc9,150$299.4K0.18%
Inspire Advisors, LLC8,423$275.6K0.02%
Seven Fleet Capital Management LP7,745$255.4K0.04%
Entropy Technologies, LP7,680$251.3K0.01%
Prelude Capital Management, LLC7,592$248.4K0.02%
Magnetar Financial LLC6,270$205.2K0.00%
Quantbot Technologies LP1,044$34.2K0.00%
Pacer Advisors, Inc.731$24.0K0.00%
Optiver Holding B.V.668$21.9K0.00%
Quarry LP478$15.6K0.00%
SRS Capital Advisors, Inc.373$12.2K0.00%
Global Retirement Partners, LLC35$1.15K0.00%
Dogwood Wealth Management LLC24$7850.00%
Strengthening Families & Communities, LLC20$6540.00%
SJS Investment Consulting Inc.10$3280.00%
Nykredit A/S10$3270.00%
Ameritas Advisory Services, LLC9$2940.00%
National Bank of Canada8$2620.00%
Clearstead Advisors, LLC3$990.00%

Sold out (29)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (2)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STOK in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC1,612,781$52.5M
CWM, LLC619$20.2K